2 New Hepatitis C Treatment Articles at HIVandHepatitis.com

[Guest guest]

HCV Polymerase Inhibitor PSI-938 Gets Fast Track

StatusThe U.S. Food and Drug Administration (FDA) last

week granted a " fast track " designation for PSI-938, an

investigational nucleotide analog hepatitis C virus

(HCV) polymerase inhibitor being developed by

Pharmasset.FDA Approves Pegasys plus Ribavirin for

Children with Chronic Hepatitis CThe

U.S. Food and Drug Administration (FDA) has approved pegyalted

interferon alfa-2a (brand name Pegasys) plus ribavirin

(brand name Copegus) for previously untreated children

and adolescents age 5-17 with chronic hepatitis C virus

(HCV) infection.